Tumor necrosis factor α decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in crohn disease

American Journal of Pathology

Volumn 185, Issue 1, 2015, Pages 185-196

  Tsukahara, Takuya ^a   Watanabe, Kenji ^a   Watanabe, Toshio ^a   Yamagami, Hirokazu ^a   Sogawa, Mitsue ^a   Tanigawa, Tetsuya ^a   Shiba, Masatsugu ^a   Tominaga, Kazunari ^a   Fujiwara, Yasuhiro ^a   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; GLUCAGON LIKE PEPTIDE 2; GW 1100; GW 9508; LINOLEIC ACID; MESSENGER RNA; PROGLUCAGON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; BENZOIC ACID DERIVATIVE; CYTOKINE; FFAR1 PROTEIN, HUMAN; GW1100; GW9508; METHYLAMINE; O3FAR1 PROTEIN, HUMAN; PROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM MUCOSA; INFLAMMATION; L CELL LINE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CASE CONTROL STUDY; CHEMISTRY; COHORT ANALYSIS; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; SPRAGUE DAWLEY RAT; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BENZOATES; CASE-CONTROL STUDIES; COHORT STUDIES; CROHN DISEASE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 2; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTESTINAL MUCOSA; MALE; METHYLAMINES; MIDDLE AGED; PROPIONATES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84918779133     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.09.010     Document Type: Article

References (50)

1. S.R. Targan, S.B. Hanauer, S.J.H. van Deventer, L. Mayer, D.H. Present, T. Braakman, K.L. DeWoody, T.F. Schaible, and P.J. Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease N Engl J Med 337 1997 1029 1035
2. S.B. Hanauer, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, J.F. Colombel, D. Rachmilewitz, D.C. Wolf, A. Olson, W.H. Bao, P. Rutgeerts ACCENT I Study Group Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 2002 1541 1549
3. L. van Bloemendaal, J.S. Ten Kulve, S.E. la Fleur, R.G. Ijzerman, and M. Diamant Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS J Endocrinol 221 2014 T1 T16
4. D.J. Drucker The biology of incretin hormones Cell Metab 3 2006 153 165
5. M.P. Plummer, K.L. Jones, C.E. Annink, C.E. Cousins, J.J. Meier, M.J. Chapman, M. Horowitz, and A.M. Deane Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects Diabetes Care 37 2014 1509 1515
6. A.R. Meloni, M.B. DeYoung, C. Lowe, and D.G. Parkes GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence Diabetes Obes Metab 15 2013 15 27
7. D.J. Drucker Glucagon-like peptide 2 J Clin Endocrinol Metab 86 2001 1759 1764
8. X. Guan, X. Shi, X. Li, B. Chang, Y. Wang, D. Li, and L. Chan GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility Am J Physiol Endocrinol Metab 303 2012 E853 E864
9. J.J. Meier, M.A. Nauck, A. Pott, K. Heinze, O. Goetze, K. Bulut, W.E. Schmidt, B. Gallwitz, and J.J. Holst Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans Gastroenterology 130 2006 44 54
10. R.P. Boushey, B. Yusta, and D.J. Drucker Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Am J Physiol Endocrinol Metab 277 1999 E937 E947
11. D.J. Drucker, B. Yusta, R.P. Boushey, L. DeForest, and P.L. Brubaker Human Gly(2) GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis Am J Physiol Gastrointest Liver Physiol 276 1999 G79 G91
12. M.C. L'Heureux, and P.L. Brubaker Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis J Pharmacol Exp Ther 306 2003 347 354
13. K. Alavi, M.Z. Schwartz, J.P. Palazzo, and R. Prasad Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2 J Pediatr 35 2000 847 851
14. G.L. Arthur, M.Z. Schwartz, K.A. Kuenzler, and R. Birbe Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease J Pediatr Surg 39 2004 448 452
15. A.L. Buchman, S. Katz, J.C. Fang, C.N. Bernstein, S.G. Abou-Assi Teduglutide Study Group Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease Inflamm Bowel Dis 16 2010 962 973
16. P.B. Jeppesen, M. Pertkiewicz, B. Messing, K. Iyer, D.L. Seidner, S.J.D. O'Keefe, A. Forbes, H. Heinze, and B. Joelsson Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure Gastroenterology 143 2012 1473 1481
17. P.B. Jeppesen, R. Gilroy, M. Pertkiewicz, J.P. Allard, B. Messing, and S.J. O'Keefe Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome Gut 60 2011 902 914
18. S. Dhanvantari, N.G. Seidah, and P.L. Brubaker Role of prohormone convertases in the tissue-specific processing of proglucagon Mol Endocrinol 10 1996 342 355
19. Y. Rouille, S. Martin, and D.F. Steiner Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide J Biol Chem 270 1995 26488 26496
20. L. Drozdowski, and A.B.R. Thomson Intestinal hormones and growth factors: effects on the small intestine World J Gastroenterol 15 2009 385 406
21. H. Izumi, S. Ishizuka, A. Inafune, T. Hira, K. Ozawa, T. Shimizu, M. Takase, and H. Hara alpha-Lactalbumin hydrolysate stimulates glucagon-like peptide-2 secretion and small intestinal growth in suckling rats J Nutr 139 2009 1322 1327
22. I.R. Ipharraguerre, G. Tedo, D. Menoyo, N.D. Cabero, J.J. Holst, M. Nofrarias, A. Mereu, and D.G. Burrin Bile acids induce glucagon-like peptide 2 secretion with limited effects on intestinal adaptation in early weaned pigs J Nutr 143 2013 1899 1905
23. A. Ulloa-Aguirre, D. Stanislaus, J.A. Janovick, and P.M. Conn Structure-activity relationships of G protein-coupled receptors Arch Med Res 30 1999 420 435
24. U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors Endocr Rev 21 2000 90 113
25. N.E. Nilsson, K. Kotarsky, C. Owman, and B. Olde Identification of a free fatty acid receptor, FFA(2)R, expressed on leukocytes and activated by short-chain fatty acids Biochem Biophys Res Commun 303 2003 1047 1052
26. A.J. Brown, S.M. Goldsworthy, A.A. Barnes, M.M. Eilert, L. Tcheang, D. Daniels, A.I. Muir, M.J. Wigglesworth, I. Kinghorn, N.J. Fraser, N.B. Pike, J.C. Strum, K.M. Steplewski, P.R. Murdock, J.C. Holder, F.H. Marshall, P.G. Szekeres, S. Wilson, D.M. Ignar, S.M. Foord, A. Wise, and S.J. Dowell The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids J Biol Chem 278 2003 11312 11319
27. E. Le Poul, C. Loison, S. Struyf, J.Y. Springael, V. Lannoy, M.E. Decobecq, S. Brezillon, V. Dupriez, G. Vassart, J. Van Damme, M. Parmentier, and M. Detheux Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation J Biol Chem 278 2003 25481 25489
28. S. Edfalk, P. Steneberg, and H. Edlund Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion Diabetes 57 2008 2280 2287
29. A.M. Habib, P. Richards, G.J. Rogers, F. Reimann, and F.M. Gribble Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells Diabetologia 56 2013 1413 1416
30. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, M. Yamada, Y. Sugimoto, S. Miyazaki, and G. Tsujimoto Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat Med 11 2005 90 94
31. T. Hira, T. Mochida, K. Miyashita, and H. Hara GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats Am J Physiol Gastrointest Liver Physiol 297 2009 G663 G671
32. S. Katsuma, A. Hirasawa, and G. Tsujimoto Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 Biochem Biophys Res Commun 329 2005 386 390
33. C.P. Briscoe, A.J. Peat, S.C. McKeown, D.F. Corbett, A.S. Goetz, T.R. Littleton, D.C. McCoy, T.P. Kenakin, J.L. Andrews, C. Ammala, J.A. Fornwald, D.M. Ignar, and S. Jenkinson Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules Br J Pharmacol 148 2006 619 628
34. D.V. Bohorquez, R. Chandra, L.A. Samsa, S.R. Vigna, and R.A. Liddle Characterization of basal pseudopod-like processes in ileal and colonic PYY cells J Mol Histol 42 2011 3 13
35. P.T. Schmidt, T. Ljung, B. Hartmann, K.J. Hare, J.J. Holst, and P.M. Hellstrom Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY Eur J Gastroenterol Hepatol 17 2005 207 212
36. J.R. Gamble, J.M. Harlan, S.J. Klebanoff, and M.A. Vadas Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor Proc Natl Acad Sci U S A 82 1985 8667 8671
37. T.M. Carlos, and J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101
38. S.E. Plevy, C.J. Landers, J. Prehn, N.M. Carramanzana, R.L. Deem, D. Shealy, and S.R. Targan A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease J Immunol 159 1997 6276 6282
39. P. Saren, H.G. Welgus, and P.T. Kovanen TNF-alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages J Immunol 157 1996 4159 4165
40. H.S. Kim, Y.C. Hwang, S.H. Koo, K.S. Park, M.S. Lee, K.W. Kim, and M.K. Lee PPAR-gamma activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic beta-cells PLoS One 8 2013 e50128
41. M. Fredborg, P.K. Theil, B.B. Jensen, and S. Purup G protein-coupled receptor120 (GPR120) transcription in intestinal epithelial cells is significantly affected by bacteria belonging to the Bacteroides, Proteobacteria, and Firmicutes phyla J Anim Sci 90 2012 10 12
42. A. Salehi, E. Flodgren, N.E. Nilsson, J. Jimenez-Feltstrom, J. Miyazaki, C. Owman, and B. Olde Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion Cell Tissue Res 322 2005 207 215
43. H.N. Suh, H.T. Huong, C.H. Song, J.H. Lee, and H.J. Han Linoleic acid stimulates gluconeogenesis via Ca2+/PLC, cPLA(2), and PPAR pathways through GPR40 in primary cultured chicken hepatocytes Am J Physiol Cell Physiol 295 2008 C1518 C1527
44. K. Fujiwara, F. Maekawa, and T. Yada Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release Am J Physiol Endocrinol Metab 289 2005 E670 E677
45. D.Y. Oh, S. Talukdar, E.J. Bae, T. Imamura, H. Morinaga, W.Q. Fan, P.P. Li, W.J. Lu, S.M. Watkins, and J.M. Olefsky GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 2010 687 698
46. S. Hafner, H.S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch Mechanism of inhibition of Raf-1 by protein kinase A Mol Cell Biol 14 1994 6696 6703
47. Q.R. Liu, P.W. Zhang, Z.C. Lin, Q.F. Li, A.S. Woods, J. Troncoso, and G.R. Uhl GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA Biochem J 377 2004 171 181
48. G.E. Bergonzelli, E.K.O. Kruithof, and R.L. Medcalf Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3′,5′-monophosphate Endocrinology 131 1992 1467 1472
49. N. Sakamoto, S. Kono, K. Wakai, Y. Fukuda, A. Satomi, T. Shimoyama, Y. Inaba, Y. Miyake, S. Sasaki, K. Okamoto, G. Kobashi, M. Washio, T. Yokoyama, C. Date, H. Tanaka Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan Inflamm Bowel Dis 11 2005 154 163
50. A. Tjonneland, A. Olsen, K. Overvad, M.M. Bergmann, H. Boeing, G. Nagel, J. Linseisen, G. Hallmans, R. Palmqvist, H. Sjodin, G. Hagglund, G. Berglund, S. Lindgren, O. Grip, D. Palli, G. Masala, N.E. Day, R. Luben, A. Welch, K.T. Khaw, S. Bingham, E. Riboli, H. Kennedy, A. Hart, A. Danielsson IBD in EPIC Study Investigators Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study Gut 58 2009 1606 1611